Healthcare - Biotechnology - NASDAQ - US
$ 1.845
5.73 %
$ 47.1 M
Market Cap
-1.63
P/E
INCOME STATEMENT
55.2 K
REVENUE
-22.3 M
OPERATING INCOME
-22.3 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Gain Therapeutics, Inc.
| Revenue | 55.2 K |
| Cost Of Revenue | 11.4 M |
| Gross Profit | -11.3 M |
| Operating Expenses | 22.3 M |
| Operating Income | -22.3 M |
| Other Expenses | 14.4 K |
| Net Income | -22.3 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 55.2 K | 0.1 | 0.2 | 28.9 K | 41.3 K | 20.6 K |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 11.4 | 64.2 K | 7.2 | 2.3 | 0 | 0 |
| Gross Profit | (11.3) | 75.9 K | (7.0) | (2.2) | 41.3 K | 20.6 K |
| OPERATING INCOME | ||||||
| Operating Expenses | 22.3 | 17.9 | 14.0 | 3.5 | 2.1 | 1.0 |
| Selling, General and Administrative Expenses | 10.8 | 9.5 | 6.8 | 1.2 | 0.6 | 0.2 |
| Research and Development Expenses | 11.5 | 8.4 | 7.2 | 2.3 | 1.6 | 0.8 |
| Operating Income | (22.3) | (17.8) | (13.8) | (3.5) | (2.1) | (1.0) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 0 | 0 | 0 | 20.5 K | 0 |
| Total Other Income | 64.9 K | 0.3 | 60.4 K | 92.8 K | 86.2 K | 67.4 K |
| Pre-Tax Income | (22.2) | (17.5) | (13.9) | (3.6) | (2.2) | (1.1) |
| NET INCOME | ||||||
| Tax Provision | 79.3 K | 93 K | 4.01 K | 5.39 K | 7.11 K | 9.78 K |
| Net Income | (22.3) | (17.6) | (13.9) | (3.6) | (2.2) | (1.1) |
| EPS | 1.71 | 1.48 | 1.37 | 0.3 | 0.18 | 0.19 |